Ranibizumab

InformationZandelisib is a potent and selective inhibitor of phosphatidylinositol 3-kinase (PI3K) with IC50 of 3.5 nM for p110δ. Zandelisib exhibits antineoplastic activity.

InformationZandelisib is a potent and selective inhibitor of phosphatidylinositol 3-kinase (PI3K) with IC50 of 3.5 nM for p110δ. Zandelisib exhibits antineoplastic activity.

InformationZandelisib is a potent and selective inhibitor of phosphatidylinositol 3-kinase (PI3K) with IC50 of 3.5 nM for p110δ. Zandelisib exhibits antineoplastic activity.

InformationZandelisib is a potent and selective inhibitor of phosphatidylinositol 3-kinase (PI3K) with IC50 of 3.5 nM for p110δ. Zandelisib exhibits antineoplastic activity.

A selective inhibitor of class I PI3K isoforms (IC₅₀s = 17, 53, and 6 nM for p110&beta, -&gamma, and -&delta, respectively) orally bioavailable, showing strong antitumor activity against human cancer xenografts in mice.

A selective inhibitor of class I PI3K isoforms (IC₅₀s = 17, 53, and 6 nM for p110&beta, -&gamma, and -&delta, respectively) orally bioavailable, showing strong antitumor activity against human cancer xenografts in mice.

A selective inhibitor of class I PI3K isoforms (IC₅₀s = 17, 53, and 6 nM for p110&beta, -&gamma, and -&delta, respectively) orally bioavailable, showing strong antitumor activity against human cancer xenografts in mice.

A selective inhibitor of class I PI3K isoforms (IC₅₀s = 17, 53, and 6 nM for p110&beta, -&gamma, and -&delta, respectively) orally bioavailable, showing strong antitumor activity against human cancer xenografts in mice.

ZYF0033 (HPK1-IN-22, compound ZYF0033) is a hematopoietic progenitor kinase 1 (HPK1) inhibitor with an IC 50 less than 10 nM based on the phosphorylation inhibition of MBP protein. ZYF0033 decreases the phosphorylation of SLP76 (serine 376). ZYF0033

ZYF0033 (HPK1-IN-22, compound ZYF0033) is a hematopoietic progenitor kinase 1 (HPK1) inhibitor with an IC 50 less than 10 nM based on the phosphorylation inhibition of MBP protein. ZYF0033 decreases the phosphorylation of SLP76 (serine 376). ZYF0033

ZYF0033 (HPK1-IN-22, compound ZYF0033) is a hematopoietic progenitor kinase 1 (HPK1) inhibitor with an IC 50 less than 10 nM based on the phosphorylation inhibition of MBP protein. ZYF0033 decreases the phosphorylation of SLP76 (serine 376). ZYF0033

ZYF0033 (HPK1-IN-22, compound ZYF0033) is a hematopoietic progenitor kinase 1 (HPK1) inhibitor with an IC 50 less than 10 nM based on the phosphorylation inhibition of MBP protein. ZYF0033 decreases the phosphorylation of SLP76 (serine 376). ZYF0033